IM Cannabis (IMCC) Capital Expenditures (2020 - 2026)

IM Cannabis' Capital Expenditures history runs 7 years deep, the most recent figure standing at -$3646.0 for Q1 2026.

• On a quarterly basis, Capital Expenditures changed N/A year-over-year to -$3646.0 in Q1 2026; TTM through Mar 2026 was $210375.7, a N/A change from a year earlier, with the FY2025 full-year figure at $9322.1, down 91.82% from the prior year.
• Capital Expenditures retreated to -$3646.0 in Q1 2026 per IMCC's latest filing, from $15058.8 in the prior quarter.
• Across five years, Capital Expenditures topped out at $832963.3 in Q4 2023 and bottomed at -$538422.2 in Q1 2022.
• The 5-year median for Capital Expenditures is -$45401.5 (2024), against an average of -$48105.7.
• Across the five-year window, Capital Expenditures plunged 111.75% in 2022 and jumped 742.42% in 2023, its largest moves.
• Year by year, Capital Expenditures stood at -$129659.7 in 2022, then soared by 742.42% to $832963.3 in 2023, then sank by 75.76% to $201869.5 in 2024, then sank by 92.54% to $15058.8 in 2025, then sank by 124.21% to -$3646.0 in 2026.
• Per Business Quant, the three latest IMCC Capital Expenditures figures stand at -$3646.0 (Q1 2026), $15058.8 (Q4 2025), and -$2906.5 (Q3 2025).